These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 30913346)

  • 21. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
    Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
    Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a miRNA-seq based prognostic signature in lung adenocarcinoma.
    Siriwardhana C; Khadka VS; Chen JJ; Deng Y
    BMC Cancer; 2019 Jan; 19(1):34. PubMed ID: 30621620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
    He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
    J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma.
    Oduor CI; Kaymaz Y; Chelimo K; Otieno JA; Ong'echa JM; Moormann AM; Bailey JA
    BMC Cancer; 2017 Nov; 17(1):761. PubMed ID: 29132323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA signature of small-cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control.
    Tanigawa K; Misono S; Mizuno K; Asai S; Suetsugu T; Uchida A; Kawano M; Inoue H; Seki N
    Mol Oncol; 2023 Feb; 17(2):328-343. PubMed ID: 36345848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
    Feng H; Zhang Z; Qing X; French SW; Liu D
    Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentially Expressed miRNAs Influence Metabolic Processes in Pituitary Oncocytoma.
    Krokker L; Nyírő G; Reiniger L; Darvasi O; Szücs N; Czirják S; Tóth M; Igaz P; Patócs A; Butz H
    Neurochem Res; 2019 Oct; 44(10):2360-2371. PubMed ID: 30945144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-30a-3p Suppresses the Growth and Development of Lung Adenocarcinoma Cells Through Modulating GOLM1/JAK-STAT Signaling.
    Ding D; Zhang Y; Zhang X; Shi K; Shang W; Ying J; Wang L; Chen Z; Hong H
    Mol Biotechnol; 2022 Oct; 64(10):1143-1151. PubMed ID: 35438415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms.
    Chen Q; Hu H; Jiao D; Yan J; Xu W; Tang X; Chen J; Wang J
    Oncol Rep; 2016 Aug; 36(2):909-17. PubMed ID: 27277197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
    Sharma P; Saraya A; Sharma R
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
    Li J; Gu X; Gao C; Zhang J
    Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
    Yu H; Pang Z; Li G; Gu T
    J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
    Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
    Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study.
    Świtlik WZ; Karbownik MS; Suwalski M; Kozak J; Szemraj J
    Genet Test Mol Biomarkers; 2019 May; 23(5):353-358. PubMed ID: 30950648
    [No Abstract]   [Full Text] [Related]  

  • 37. A panel of miRNAs derived from plasma extracellular vesicles as novel diagnostic biomarkers of lung adenocarcinoma.
    Yao B; Qu S; Hu R; Gao W; Jin S; Liu M; Zhao Q
    FEBS Open Bio; 2019 Dec; 9(12):2149-2158. PubMed ID: 31677346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
    Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
    Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Value of MiR-125b as a Potential Biomarker for Stage I Lung Adenocarcinoma.
    Zeybek A; Öz N; Kalemci S; Edgünlü T; Kızıltuğ MT; Tosun K; Tunç M; Tekin L; Erdal ME
    Curr Mol Med; 2019; 19(3):216-227. PubMed ID: 30868951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes.
    Mizuno K; Mataki H; Arai T; Okato A; Kamikawaji K; Kumamoto T; Hiraki T; Hatanaka K; Inoue H; Seki N
    J Hum Genet; 2017 Jul; 62(7):671-678. PubMed ID: 28275243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.